Correspondence
- PMID: 26655619
- DOI: 10.1097/IAE.0000000000000917
Correspondence
Comment in
-
Reply.Retina. 2016 Feb;36(2):e10-2. doi: 10.1097/IAE.0000000000000918. Retina. 2016. PMID: 26696314 No abstract available.
Comment on
-
Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.Retina. 2014 Dec;34(12):2439-43. doi: 10.1097/IAE.0000000000000238. Retina. 2014. PMID: 24999721
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
